The use of the peroxisome proliferator-activated receptors γ agonist rosiglitazone to treat airway hyperreactivity

Journal article

Peer reviewed

Manbir Singh Sandhu, Vesselin Dimov, Arveen Kaur Sandhu, Ryan W. Walters, Tammy Wichman and Thomas Casale

Annals of Allergy, Asthma and Immunology, Vol.109(1), pp.75-77

109

07/2012

PMID: 22727164

Abstract

Immunology and Allergy

Immunology

Pulmonary and Respiratory Medicine

4 Record Views

Title: The use of the peroxisome proliferator-activated receptors γ agonist rosiglitazone to treat airway hyperreactivity
Creators: Manbir Singh Sandhu (Author) - Creighton University
Vesselin Dimov (Author) - Creighton University
Arveen Kaur Sandhu (Author) - Creighton University
Ryan W. Walters (Author) - Department of Medicine
Tammy Wichman (Author) - Creighton University
Thomas Casale (Author) - Creighton University
Publication Details: Annals of Allergy, Asthma and Immunology, Vol.109(1), pp.75-77
Series: 109
Number of pages: 3
Identifiers: 991005929689102656
Academic Unit: General Medicine
Language: English
Resource Type: Journal article